サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1378595

脊髄損傷治療薬市場：薬剤タイプ別、適応症別、用途別、投与経路別、流通チャネル別、地域別

Spinal Cord Injury Therapeutics Market, By Drug Type, By Indication, By Application, By Route of Administration, By Distribution Channel, By Geography

出版日
ページ情報
英文 190 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=148.90円
脊髄損傷治療薬市場：薬剤タイプ別、適応症別、用途別、投与経路別、流通チャネル別、地域別
出版日: 2023年10月12日
発行: Coherent Market Insights
ページ情報: 英文 190 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

脊髄損傷治療薬の世界市場規模は2023年に74億米ドルと推定・予測され、予測期間中（2023～2030年）のCAGRは5.4%と予測されます。

レポート対象範囲 レポート詳細
基準年 2022年 2023年の市場規模 74億米ドル
実績データ 2018年～2021年 予測期間 2023-2030
予測期間のCAGR 5.40% 2030年の市場規模予測 107億米ドル
図1.脊髄損傷治療薬の世界市場シェア（％）、適応症別、2023年
Spinal Cord Injury Therapeutics Market-IMG1

脊髄損傷とは、31組の脊髄神経に生じる傷のことで、脊髄神経は精神からの神経信号を身体のさまざまな部位に伝えるとともに、腕や脚の発育を制御しています。脊髄の傷の基本的な原因には、傷害、脊髄への血液供給の喪失、がんや汚染による脊髄の圧迫などがあります。脊髄の傷は、例えばXビーム、魅力的な残響記録（MRI）、フィギュアド・トモグラフィー（CT）など、さまざまな方法の助けを借りて判断することができます。製薬業界の主な企業は、脊髄損傷の治療に関連する薬剤の開発に注力しています。したがって、このような先進的な製品が市場にイントロダクションされることで、予測期間中、世界の脊髄損傷治療薬市場の成長が促進されると予想されます。

市場力学

製薬業界の主な企業は、脊髄損傷治療のための新薬開発に注力しています。そのため、このような先進的な製品が市場にイントロダクションされることで、予測期間にわたって世界の脊髄損傷治療薬市場の成長が促進されると予想されます。例えば、2022年6月、完全統合型の必須医薬品企業であるAmneal Pharmaceuticals, Inc.は、多発性硬化症やその他の脊髄障害に関連する痙縮の治療薬として米国食品医薬品局（FDA）から承認されたバクロフェン経口顆粒（5、10、20mg）専門製品であるLYVISPAHの商業的発売を発表しました。

本調査の主な特徴

  • 本レポートでは、世界の脊髄損傷治療薬市場を詳細に分析し、2022年を基準年とした予測期間（2023～2030年）の市場規模および年間平均成長率（CAGR）を掲載しています。また、さまざまなセグメントにわたる潜在的な収益成長機会を明らかにし、この市場に対する魅力的な投資提案のマトリックスについて解説しています。
  • また、市場促進要因、抑制要因、機会、新製品の上市や承認、市場動向、地域別の展望、主要企業が採用する競争戦略などに関する主要考察も提供しています。
  • 世界の脊髄損傷治療薬市場における主な企業を、企業ハイライト、製品ポートフォリオ、主要ハイライト、業績、戦略などのパラメータに基づいてプロファイルしています。
  • 本調査の対象となる主要企業には、Teva Pharmaceutical Industries Ltd.、AbbVie Inc.、Pfizer Inc.、Reddy's Laboratories Ltd.、Zydus Cadila、ReNetX Bio, Inc.、InVivo Therapeutics Holdings、Lineage Cell Therapeutics, Inc.、Kringle Pharma, Inc、NervGen社、Rising Pharmaceuticals社、ScieGen Pharmaceuticals社、MSN Laboratories Private Limited、Lannett Co Inc.
  • 本レポートからの洞察により、マーケティング担当者や企業の経営陣は、将来の製品発売、タイプアップ、市場拡大、マーケティング戦術に関する情報に基づいた意思決定を行うことができます。
  • 脊髄損傷治療薬の世界市場レポートは、投資家、サプライヤー、製品メーカー、流通業者、新規参入者、財務アナリストなど、この業界の様々な利害関係者を対象としています。
  • 利害関係者は、世界の脊髄損傷治療薬市場の分析に使用される様々な戦略マトリックスを通じて、意思決定が容易になります。

目次

第1章 調査の目的と前提

  • 調査の目的
  • 仮定
  • 略語

第2章 市場展望

  • レポートの説明
    • 市場の定義と範囲
  • エグゼクティブサマリー
  • Coherent Opportunity Map（COM）

第3章 市場力学、規制、動向分析

  • 市場力学
    • 促進要因
    • 抑制要因
    • 市場機会
  • 影響分析
  • 最近のテスト打ち上げ
  • 疫学
  • 合併、買収、およびコラボレーション
  • 規制シナリオ
  • 主な発展
  • PEST分析

第4章 世界の脊髄損傷治療薬市場- 新型コロナウイルス感染症（COVID-19）の影響分析

  • 経済的影響
  • 新型コロナウイルス感染症（COVID-19）の疫学
  • 需要と供給への影響

第5章 世界の脊髄損傷治療薬市場、薬剤タイプ別、2018～2030年

  • コルチコステロイド
  • 筋弛緩薬と抗けいれん薬
  • 非ステロイド性抗炎症薬（NSAID'S）
  • 抗うつ薬
  • 抗けいれん薬
  • その他

第6章 世界の脊髄損傷治療薬市場、適応症別、2018～2030年

  • 完全脊髄損傷
  • 不完全脊髄損傷

第7章 世界の脊髄損傷治療薬市場、用途別、2018～2030年

  • 自律神経失調症（AD）
  • 痙縮と炎症
  • 疼痛管理
  • うつ

第8章 世界の脊髄損傷治療薬市場、投与経路別、2018～2030年

  • 経口
  • 静脈内

第9章 世界の脊髄損傷治療薬市場、流通チャネル別、2018年～2030年

  • 病院薬局
  • 小売薬局
  • オンライン薬局

第10章 世界の脊髄損傷治療薬市場、地域別、2018～2030年

  • 北米
  • 米国
  • カナダ
  • 欧州
  • 英国
  • ドイツ
  • イタリア
  • フランス
  • スペイン
  • ロシア
  • その他欧州
  • アジア太平洋地域
  • 中国
  • インド
  • 日本
  • ASEAN
  • オーストラリア
  • 韓国
  • その他アジア太平洋地域
  • ラテンアメリカ
  • ブラジル
  • メキシコ
  • アルゼンチン
  • その他ラテンアメリカ
  • 中東
  • GCC
  • イスラエル
  • その他中東
  • アフリカ
  • 北アフリカ
  • 中央アフリカ
  • 南アフリカ

第11章 競合情勢

  • 企業プロファイル
    • Teva Pharmaceutical Industries Ltd.
    • AbbVie Inc
    • Pfizer Inc.
    • Reddy's Laboratories Ltd
    • Zydus Cadila
    • ReNetX Bio, Inc
    • InVivo Therapeutics Holdings
    • Lineage Cell Therapeutics, Inc
    • Kringle Pharma, Inc.
    • Acorda Therapeutics, Inc.
    • Bioaxone Biosciences, Inc
    • RespireRx Pharmaceuticals Inc.
    • NervGen
    • Rising Pharmaceuticals, Inc
    • ScieGen Pharmaceuticals, Inc
    • MSN Laboratories Private Limited
    • Lannett Co Inc.
    • Other Prominent Players

第12章 セクション

  • 参考文献
  • 調査手法
目次
Product Code: CMI4305

The Global Spinal Cord Injury Therapeutics Market is estimated to be valued at US$ 7.4 billion in 2023 and is expected to exhibit a CAGR of 5.4% during the forecast period (2023-2030).

Report Coverage Report Details
Base Year: 2022 Market Size in 2023: US$ 7.4 Bn
Historical Data for: 2018 to 2021 Forecast Period: 2023 - 2030
Forecast Period 2023 to 2030 CAGR: 5.40% 2030 Value Projection: US$ 10.7 Bn
Figure 1. Global Spinal Cord Injury Therapeutics Market Share (%), By Indication, 2023
Spinal Cord Injury Therapeutics Market - IMG1

Spinal cord wounds are the wounds caused to the 31 sets of spinal nerves, which convey nerve signals from the mind to different parts of the body and likewise control the arm and leg developments. The fundamental driver of spinal cord wounds incorporate injury, loss of blood supply to the spinal cord, and pressure in the spinal cord because of cancer or contamination. Spinal cord wounds can be determined to have the assistance of different methods, for example, X-beam, attractive reverberation record (MRI), and figured tomography (CT). Key players in the pharmaceutical industry are focusing on the development of drugs associated with the treatment of spinal cord injuries. Thus, the introduction of such advanced products in the market is expected to drive the growth of the global spinal cord injury therapeutics market over the forecast period.

Market Dynamics

The key players in the pharmaceutical industry are focusing on the development of new drugs for spinal cord injury treatment. Thus, the introduction of such advanced products in the market is expected to drive growth of the global spinal cord injury therapeutics market over the forecast period. For instance, in June 2022, Amneal Pharmaceuticals, Inc., a fully integrated essential medicines company, announced the commercial launch of LYVISPAH, a baclofen oral granules (5, 10 and 20 mg) specialty product approved by the U.S. Food and Drug Administration (FDA) for the treatment of spasticity related to multiple sclerosis and other spinal cord disorders.

Key features of the study:

  • This report provides an in-depth analysis of the global spinal cord injury therapeutics market and provides market size (US$ Billion) and Compound Annual Growth Rate (CAGR) for the forecast period (2023-2030), considering 2022 as the base year. It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market.
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global spinal cord injury therapeutics market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
  • The key companies covered as a part of this study include Teva Pharmaceutical Industries Ltd., AbbVie Inc, Pfizer Inc., Reddy's Laboratories Ltd, Zydus Cadila, ReNetX Bio, Inc, InVivo Therapeutics Holdings, Lineage Cell Therapeutics, Inc, Kringle Pharma, Inc., Acorda Therapeutics, Inc., Bioaxone Biosciences, Inc, RespireRx Pharmaceuticals Inc., NervGen, Rising Pharmaceuticals, Inc, ScieGen Pharmaceuticals, Inc, MSN Laboratories Private Limited, and Lannett Co Inc.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The global spinal cord injury therapeutics market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global spinal cord injury therapeutics market

Global Spinal Cord Injury Therapeutics Market Detailed Segmentation:

  • By Drug Type:
    • Corticosteroids
    • Muscle Relaxants and Anti-spastic drugs
    • Non-steroidal Anti-inflammatory drugs (NSAID'S)
    • Anti-depressants
    • Anticonvulsants
    • Others
  • By Indication:
    • Complete Spinal Cord Injury
    • Incomplete Spinal Cord Injury
  • By Application:
    • Autonomic Dysreflexia (AD)
    • Spasticity and Inflammation
    • Pain Management
    • Depression
  • By Route of Administration:
    • Oral
    • Intravenous
  • By Distribution Channel:
    • Hospital Pharmacies
    • Retail Pharmacies
    • Online Pharmacies
  • By Region:
    • North America
    • Latin America
    • Europe
    • Asia Pacific
    • Middle East
    • Africa
  • Company Profiles
    • Teva Pharmaceutical Industries Ltd.
    • AbbVie Inc
    • Pfizer Inc.
    • Reddy's Laboratories Ltd
    • Zydus Cadila
    • ReNetX Bio, Inc
    • InVivo Therapeutics Holdings
    • Lineage Cell Therapeutics, Inc
    • Kringle Pharma, Inc.
    • Acorda Therapeutics, Inc.
    • Bioaxone Biosciences, Inc
    • RespireRx Pharmaceuticals Inc.
    • NervGen
    • Rising Pharmaceuticals, Inc
    • ScieGen Pharmaceuticals, Inc
    • MSN Laboratories Private Limited
    • Lannett Co Inc.
    • Other Prominent Players

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snippet, By Drug Type
    • Market Snippet, By Indication
    • Market Snippet, By Application
    • Market Snippet, By Route of Administration
    • Market Snippet, By Distribution Channel
    • Market Snippet, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Market Opportunities
  • Impact Analysis
  • Recent Test Launches
  • Epidemiology
  • Merger, Acquisition, and Collaborations
  • Regulatory Scenario
  • Key Developments
  • PEST Analysis

4. Global Spinal Cord Injury Therapeutics Market - COVID-19 Impact Analysis

  • Economic Impact
  • COVID-19 Epidemiology
  • Impact on Supply and Demand

5. Global Spinal Cord Injury Therapeutics Market, By Drug Type, 2018 - 2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2018-2030
    • Segment Trends
  • Corticosteroids
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
    • Segment Trends
  • Muscle Relaxants and Anti-spastic Drugs
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
    • Segment Trends
  • Non-steroidal Anti-inflammatory Drugs (NSAID'S)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
    • Segment Trends
  • Anti-depressants
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
    • Segment Trends
  • Anticonvulsants
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
    • Segment Trends
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
    • Segment Trends

6. Global Spinal Cord Injury Therapeutics Market, By Indication, 2018 - 2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2018-2030
    • Segment Trends
  • Complete Spinal Cord Injury
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
    • Segment Trends
  • Incomplete Spinal Cord Injury
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
    • Segment Trends

7. Global Spinal Cord Injury Therapeutics Market, By Application, 2018 - 2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2018-2030
    • Segment Trends
  • Autonomic Dysreflexia (AD)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
    • Segment Trends
  • Spasticity and Inflammation
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
    • Segment Trends
  • Pain Management
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
    • Segment Trends
  • Depression
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
    • Segment Trends

8. Global Spinal Cord Injury Therapeutics Market, By Route of Administration, 2018 - 2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2018-2030
    • Segment Trends
  • Oral
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
    • Segment Trends
  • Intravenous
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
    • Segment Trends

9. Global Spinal Cord Injury Therapeutics Market, By Distribution Channel, 2018 - 2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2018-2030
    • Segment Trends
  • Hospital Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
    • Segment Trends
  • Retail Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
    • Segment Trends
  • Online Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
    • Segment Trends

10. Global Spinal Cord Injury Therapeutics Market, By Region, 2018 - 2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2018-2030
    • Segment Trends
  • North America
    • Introduction
    • Market Size and Forecast, Y-o-Y Growth and By Drug Type, 2018 - 2030, (US$ Bn)
    • Market Size and Forecast, Y-o-Y Growth and By Indication, 2018 - 2030, (US$ Bn
    • Market Size and Forecast, Y-o-Y Growth and By Application, 2018 - 2030, (US$ Bn)
    • Market Size and Forecast, Y-o-Y Growth and By Route of Administration, 2018 - 2030, (US$ Bn)
    • Market Size and Forecast, Y-o-Y Growth and By Distribution Channel, 2018 - 2030, (US$ Bn)
    • Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018 - 2030, (US$ Bn)
  • U.S.
  • Canada
  • Europe
    • Introduction
    • Market Size and Forecast, Y-o-Y Growth and By Drug Type, 2018 - 2030, (US$ Bn)
    • Market Size and Forecast, Y-o-Y Growth and By Indication, 2018 - 2030, (US$ Bn
    • Market Size and Forecast, Y-o-Y Growth and By Application, 2018 - 2030, (US$ Bn)
    • Market Size and Forecast, Y-o-Y Growth and By Route of Administration, 2018 - 2030, (US$ Bn)
    • Market Size and Forecast, Y-o-Y Growth and By Distribution Channel, 2018 - 2030, (US$ Bn)
    • Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018 - 2030, (US$ Bn)
  • U.K.
  • Germany
  • Italy
  • France
  • Spain
  • Russia
  • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, Y-o-Y Growth and By Drug Type, 2018 - 2030, (US$ Bn)
    • Market Size and Forecast, Y-o-Y Growth and By Indication, 2018 - 2030, (US$ Bn
    • Market Size and Forecast, Y-o-Y Growth and By Application, 2018 - 2030, (US$ Bn)
    • Market Size and Forecast, Y-o-Y Growth and By Route of Administration, 2018 - 2030, (US$ Bn)
    • Market Size and Forecast, Y-o-Y Growth and By Distribution Channel, 2018 - 2030, (US$ Bn)
    • Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018 - 2030, (US$ Bn)
  • China
  • India
  • Japan
  • ASEAN
  • Australia
  • South Korea
  • Rest of Asia Pacific
  • Latin America
    • Introduction
    • Market Size and Forecast, Y-o-Y Growth and By Drug Type, 2018 - 2030, (US$ Bn)
    • Market Size and Forecast, Y-o-Y Growth and By Indication, 2018 - 2030, (US$ Bn
    • Market Size and Forecast, Y-o-Y Growth and By Application, 2018 - 2030, (US$ Bn)
    • Market Size and Forecast, Y-o-Y Growth and By Route of Administration, 2018 - 2030, (US$ Bn)
    • Market Size and Forecast, Y-o-Y Growth and By Distribution Channel, 2018 - 2030, (US$ Bn)
    • Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018 - 2030, (US$ Bn)
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • Middle East
    • Introduction
    • Market Size and Forecast, Y-o-Y Growth and By Drug Type, 2018 - 2030, (US$ Bn)
    • Market Size and Forecast, Y-o-Y Growth and By Indication, 2018 - 2030, (US$ Bn
    • Market Size and Forecast, Y-o-Y Growth and By Application, 2018 - 2030, (US$ Bn)
    • Market Size and Forecast, Y-o-Y Growth and By Route of Administration, 2018 - 2030, (US$ Bn)
    • Market Size and Forecast, Y-o-Y Growth and By Distribution Channel, 2018 - 2030, (US$ Bn)
    • Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018 - 2030, (US$ Bn)
  • GCC
  • Israel
  • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, Y-o-Y Growth and By Drug Type, 2018 - 2030, (US$ Bn)
    • Market Size and Forecast, Y-o-Y Growth and By Indication, 2018 - 2030, (US$ Bn
    • Market Size and Forecast, Y-o-Y Growth and By Application, 2018 - 2030, (US$ Bn)
    • Market Size and Forecast, Y-o-Y Growth and By Route of Administration, 2018 - 2030, (US$ Bn
    • Market Size and Forecast, Y-o-Y Growth and By Distribution Channel, 2018 - 2030, (US$ Bn)
    • Market Size and Forecast, By Country, Y-o-Y Growth and By Country/Region, 2018 - 2030, (US$ Bn)
  • North Africa
  • Central Africa
  • South Africa

11. Competitive Landscape

  • Company Profiles
    • Teva Pharmaceutical Industries Ltd.
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Overview
  • Strategies
    • AbbVie Inc
    • Pfizer Inc.
    • Reddy's Laboratories Ltd
    • Zydus Cadila
    • ReNetX Bio, Inc
    • InVivo Therapeutics Holdings
    • Lineage Cell Therapeutics, Inc
    • Kringle Pharma, Inc.
    • Acorda Therapeutics, Inc.
    • Bioaxone Biosciences, Inc
    • RespireRx Pharmaceuticals Inc.
    • NervGen
    • Rising Pharmaceuticals, Inc
    • ScieGen Pharmaceuticals, Inc
    • MSN Laboratories Private Limited
    • Lannett Co Inc.
    • Other Prominent Players

12. Section

  • References
  • Research Methodology
  • About us and Sales Contact